• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Managing Migraines and Diabetes? Theranica Proves Migraine Wearable is Safe to Use with CGMs

by Fred Pennic 02/27/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know

  • Theranica announced the publication of a peer-reviewed compatibility study in the Journal of Clinical Medicine. The study demonstrated that the Nerivio Remote Electrical Neuromodulation (REN) wearable can be safely used at the same time as common Continuous Glucose Monitoring (CGM) systems.
  • The concurrent use of these devices does not disrupt glucose measurement accuracy.
  • In the United States, an estimated 4.5 million people live with both diabetes and migraines. The study evaluated 21 adults using Nerivio alongside Abbott FreeStyle Libre and Dexcom systems.
  • Results showed a median glucose reading deviation of only 1.6%, which is well below the predefined 5.0% threshold. Researchers observed zero Bluetooth disruptions, missed data transmissions, device malfunctions, or adverse events during the study.

Managing Migraines and Diabetes

This technical validation addresses a massive patient population. Globally, hundreds of millions of adults and adolescents are affected by migraines and diabetes. In the United States alone, an estimated 4.5 million individuals live with both conditions.

Many of these patients rely on wireless CGM systems (like the Abbott FreeStyle Libre or Dexcom devices) that transmit continuous blood-glucose measurements to smartphone apps via Bluetooth. Because the Nerivio wearable is also controlled and monitored through a smartphone app using Bluetooth, patients and providers have frequently questioned whether the two technologies could safely coexist.

“Migraine treatment can be especially complex for individuals with diabetes because many pharmacologic options carry metabolic or cardiovascular considerations,” noted Dr. Richelle deMayo, chief medical information officer at Connecticut Children’s Research Institute and a contributing author of the study. “As connected health technologies continue to expand, confirming safe multi-device operation is increasingly important for real-world patient care.”

The Clinical Data

The repeated-measures interventional compatibility study evaluated 21 adults with diabetes. The participants used their CGM systems concurrently with a Nerivio device during a full 45-minute REN session.

Researchers compared the glucose measurements taken during active Nerivio stimulation against those taken when the stimulation was paused. The study targeted a stringent predefined mean absolute relative difference (MADR) threshold of 5.0%.

The results were highly favorable:

  • The median deviation was only 1.6%, well below the prespecified 5.0% benchmark.
  • Abbott FreeStyle Libre users demonstrated a median deviation of 1.0%.
  • Dexcom users demonstrated a median deviation of 1.7%.
  • The study observed no Bluetooth disruptions, co-interference, or missed data transmissions.
  • There were no device malfunctions or adverse events reported.

The authors conclude that simultaneous use of Nerivio and CGM systems is safe, feasible, and functionally compatible, helping remove a key barrier to integrating multiple wearable technologies for people managing comorbid migraine and diabetes.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |